OptimizeRx (NASDAQ:OPRX) and Maximus (NYSE:MMS) Financial Contrast

Maximus (NYSE:MMS) and OptimizeRx (NASDAQ:OPRX) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends.

Earnings & Valuation

This table compares Maximus and OptimizeRx”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maximus	$5.31 billion	0.85	$306.91 million	$5.00	14.91
OptimizeRx	$88.18 million	1.03	-$17.57 million	($1.33)	-3.70

Maximus has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Maximus, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Maximus has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Maximus and OptimizeRx, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maximus	0	1	0	0	2.00
OptimizeRx	0	2	7	0	2.78

OptimizeRx has a consensus target price of $9.19, suggesting a potential upside of 86.74%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Maximus.

Institutional and Insider Ownership

97.2% of Maximus shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 1.4% of Maximus shares are held by insiders. Comparatively, 6.1% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Maximus and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Maximus	5.78%	20.95%	9.28%
OptimizeRx	-27.41%	-4.92%	-3.41%

Summary

Maximus beats OptimizeRx on 8 of the 14 factors compared between the two stocks.

About Maximus

Maximus, Inc. operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The U.S. Federal Services segment offers Business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The Outside the U.S. segment offers BPS solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.